Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, and Boyd AE, 3rd
Also, side effects for GLP-1RAs in liver disease patients often include gastrointestinal issues, which can be managed with lower initial doses
A Phase Ib open label, randomized, safety study of SANGUINATE in patients with sickle cell anemia
The FDA in early 2026 publicly highlighted enforcement actions targeting non-approved GLP-1 active ingredients in compounded products, so source verification is non-negotiable
Very strange. Its a feeling described by thousands of people taking these medicines, which are in a class known as GLP-1 receptor agonists and used by an estimated 15 million Americans, according to a recent poll
In the del15q and mUPD groups, a positive correlation was found between glucose and triglyceride levels